Combined oxidative phosphorylation defect type 9 is a rare mitochondrial disease due to a defect in mitochondrial protein synthesis characterized by initially normal growth and development followed by the infantile-onset of failure to thrive, psychomotor delay, poor feeding, dyspnea, severe hypertrophic cardiomyopathy and hepatomegaly. Laboratory studies report increased plasma lactate and alanine, abnormal liver enzymes and decreased activity of mitochondrial respiratory chain complexes I, III, IV, and V.
Comprehensive, easy-to-understand information about this condition
Checking for content...
severe X-linked mitochondrial encephalomyopathy
MONDO:0010437
hepatoencephalopathy due to combined oxidative phosphorylation defect type 1
MONDO:0012191
combined oxidative phosphorylation defect type 2
MONDO:0012510
fatal mitochondrial disease due to combined oxidative phosphorylation defect type 3
MONDO:0012512
combined oxidative phosphorylation defect type 4
MONDO:0012534
hypotonia with lactic acidemia and hyperammonemia
MONDO:0012718